.png){kind=icon}
.png){kind=icon}
Return
Reassessing R&D outcomes of leading pharmaceutical companies
.png){kind=icon}
OA
AI
A
M
D
M
O
DOI：10.1016/j.drudis.2026.104763.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
• Big pharma R&D performance exceeds common assumptions. • 67% of approved drugs achieve R&D profitability. • Big pharma shows higher R&D profitability than biotech firms. • Sourcing strategy influences pharmaceutical R&D performance.
Keywords:
Pharmaceutical
big pharma
biotech
R&D productivity
R&D outcome
new drug
innovation
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
7.5
Papers:
6.3K
Citations:
2.3W
Organization
Cited Papers